Lucy Gilbert

10.1k citations

160 papers · 3.5k indexed · 2 hit papers · h-index 29

Impact in

Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
- Ovarian function and disorders
Obstetrics and Gynecology top 0.5%
- Endometrial and Cervical Cancer Treatments

Papers in ⓘ

Reproductive Medicine 74
- Ovarian cancer diagnosis and treatment 67
- Endometriosis Research and Treatment 11
Obstetrics and Gynecology 58
- Endometrial and Cervical Cancer Treatments 55

Co-authors: Ri‐Cheng Chian (4 shared papers)Seang Lin Tan (4 shared papers)Jack Y.J. Huang (4 shared papers)William Buckett (3 shared papers)David M. O’Malley (31 shared papers)Ana Oaknin (25 shared papers)Hananel Holzer (3 shared papers)Kathleen N. Moore (23 shared papers)
Journals: Journal of Clinical Oncology (28 papers)Gynecologic Oncology (24 papers)Annals of Oncology (12 papers)International Journal of Gynecological Cancer (5 papers)International Journal of Cancer (4 papers)
Partner nations: Canada United States United Kingdom

In The Last Decade

Lucy Gilbert

147 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer 2023 · 81 citations

Peers

Countries citing papers authored by Lucy Gilbert

Since Specialization

Citations

This map shows the geographic impact of Lucy Gilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Gilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Gilbert more than expected).

Fields of papers citing papers by Lucy Gilbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy Gilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Gilbert. The network helps show where Lucy Gilbert may publish in the future.

Co-authors

The 25 scholars most cited alongside Lucy Gilbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lucy Gilbert Line = papers co-authored together Lucy Gilbert links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer JAMA Oncology ·Ana Oaknin, Anna V. Tinker, Lucy Gilbert, Vanessa Samouëlian, Cara Mathews, Jubilee Brown, Maria-Pilar Barretina-Ginesta, Víctor Moreno, Adriano Gravina, Cyril Abdeddaim, Susana Banerjee, Wei Guo, Hadi Danaee, Ellie Im, Renaud Sabatier Hit paper breakdown →	2020	237
2	PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer Journal of Clinical Oncology ·R. Wendel Naumann, Robert L. Coleman, Robert A. Burger, Edward A. Sausville, E. Kutarska, Sharad Ghamande, Nashat Gabrail, Stephen DePasquale, Elżbieta Nowara, Lucy Gilbert, Robert H. Gersh, Michael Teneriello, Wael A. Harb, Panagiotis A. Konstantinopoulos, Richard T. Penson, James T. Symanowski, C. Lovejoy, Christopher P. Leamon, David Morgenstern, Richard A. Messmann	2013	169
3	A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer Gynecologic Oncology ·Katherine M. Bell‐McGuinn, Carolyn M. Matthews, Steffan N. Ho, Minal Barve, Lucy Gilbert, Richard T. Penson, Ernst Lengyel, Rameshraja Palaparthy, Kye Gilder, Artemios B. Vassos, William J. McAuliffe, Sara Weymer, Jeremy Barton, Russell J. Schilder	2011	144
4	Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes Fertility and Sterility ·Ri‐Cheng Chian, Jack Y.J. Huang, Lucy Gilbert, Weon‐Young Son, Hananel Holzer, S. Cui, William Buckett, Togas Tulandi, Seang Lin Tan	2008	143
5	Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy Menopause The Journal of The North American Menopause Society ·Fernand Labrie, David F. Archer, Céline Bouchard, Michel Fortier, Léonello Cusan, José‐Luis Gomez, Ginette Girard, Mira Baron, Normand Ayotte, Michèle Moreau, Robert Dubé, Isabelle Côté, Claude Labrie, Lyne Lavoie, Louise Berger, Lucy Gilbert, Céline Martel, John Balser	2009	138
6	Endometrial Carcinoma: MR Imaging–based Texture Model for Preoperative Risk Stratification—A Preliminary Analysis Radiology ·Yoshiko Ueno, Behzad Forghani, Reza Forghani, Anthony Dohan, Xing Zeng, Foucauld Chamming’s, Jocelyne Arseneau, Lili Fu, Lucy Gilbert, B. Gallix, Caroline Reinhold	2017	135
7	Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers JNCI Journal of the National Cancer Institute ·Andrea Eisen, Jan Lubiński, J. Gronwald, Pål Møller, H. T. Lynch, J.G.M. Klijn, Charmaine Kim‐Sing, Susan L. Neuhausen, Lucy Gilbert, P Ghadirian, Siranoush Manoukian, Gad Rennert, E. Friedman, Claudine Isaacs, Ezra Y. Rosen, Barry P. Rosen, Mary B. Daly, Ping Sun, Steven A. Narod	2008	132
8	Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women Menopause The Journal of The North American Menopause Society ·Fernand Labrie, David F. Archer, Céline Bouchard, Michel Fortier, Léonello Cusan, José‐Luis Gomez, Ginette Girard, Mira Baron, Normand Ayotte, Michèle Moreau, Robert Dubé, Isabelle Côté, Claude Labrie, Lyne Lavoie, Louise Berger, Lucy Gilbert, Céline Martel, John Balser	2009	129
9	The Meaning‐Making intervention (MMi) appears to increase meaning in life in advanced ovarian cancer: a randomized controlled pilot study Psycho-Oncology ·Mélissa Henry, S. Robin Cohen, Virginia Lee, Philippe Sauthier, Diane Provencher, Pierre Drouin, Philippe Gauthier, Walter H. Gotlieb, Susie Lau, Nancy Drummond, Lucy Gilbert, G. Stanimir, Jeremy Sturgeon, Martin Chasen, Julie A. Mitchell, Lina Huang, Mira‐Klode Ferland, Nancy E. Mayo	2010	121
10	Live birth after vitrification of in vitro matured human oocytes Fertility and Sterility ·Ri‐Cheng Chian, Lucy Gilbert, Jack Y.J. Huang, Ezgi Demirtaş, Hananel Holzer, Alice Benjamin, William Buckett, Togas Tulandi, Seang Lin Tan	2008	117
11	Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer Gynecologic Oncology ·David M. O’Malley, Ursula A. Matulonis, Michael J. Birrer, Cesar M. Castro, Lucy Gilbert, Ignace Vergote, Lainie P. Martin, Gina Mantia-Smaldone, Antonio González-Martı́n, Raquel Bratos, Richard T. Penson, Karim Malek, Kathleen N. Moore	2020	113
12	Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project The Lancet Oncology ·Lucy Gilbert, Olga Basso, John S. Sampalis, Igor Karp, Claudia Martins, Jing Feng, Sabrina Piedimonte, L Quintal, Agnihotram V. Ramanakumar, Janet Takefman, Maria S Grigorie, Giovanni Artho, Srinivasan Krishnamurthy	2012	108
13	A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. Journal of Clinical Oncology ·Lucy Gilbert, L J Elwood, Maria J. Merino, Shahla Masood, Rachel Barnes, S. M. Steinberg, Daisy F. Lazarous, Lori J. Pierce, Teresa D'Angelo, Jeffrey A. Moscow	1993	102
14	Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer Gynecologic Oncology ·Lucy Gilbert, Ana Oaknin, Ursula A. Matulonis, Gina Mantia-Smaldone, Peter Lim, Cesar M. Castro, Diane Provencher, Sanaz Memarzadeh, Michael Method, Jiuzhou Wang, Kathleen N. Moore, David M. O’Malley Hit paper breakdown →	2023	81
15	Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration Menopause The Journal of The North American Menopause Society ·Fernand Labrie, David F. Archer, Céline Bouchard, Michel Fortier, Léonello Cusan, José‐Luis Gomez, Ginette Girard, Mira Baron, Normand Ayotte, Michèle Moreau, Robert Dubé, Isabelle Côté, Claude Labrie, Lyne Lavoie, René Bérubé, Patrick Bélanger, Louise Berger, Lucy Gilbert, Céline Martel, John Balser	2009	77
16	Retrieval of immature oocytes followed by in vitro maturation and vitrification: A case report on a new strategy of fertility preservation in women with borderline ovarian malignancy Gynecologic Oncology ·Jack Y.J. Huang, William Buckett, Lucy Gilbert, Seang Lin Tan, Ri‐Cheng Chian	2007	73
17	Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia Climacteric ·Fernand Labrie, David F. Archer, Céline Bouchard, Michel Fortier, L. Cusan, J.-L. Gomez, Ginette Girard, Maayan Baron, Normand Ayotte, Michèle Moreau, Robert Dubé, Isabelle Côté, Claude Labrie, Luc Lavoie, L. Berger, Lucy Gilbert, Céline Martel, John Balser	2011	66
18	Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: A novel strategy of fertility preservation for breast cancer patients The American Journal of Surgery ·Jack Y.J. Huang, Ri‐Cheng Chian, Lucy Gilbert, David Fleiszer, Hananel Holzer, Ezgi Dermitas, Shai E. Elizur, Yariv Gidoni, Dan Levin, Weon‐Young Son, Seang Lin Tan	2010	65
19	Prognostic factors and outcome in women with uterine sarcoma European Journal of Surgical Oncology ·Dominik Denschlag, I. Masoud, G. Stanimir, Lucy Gilbert	2006	58
20	Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody–Drug Conjugate Mirvetuximab Soravtansine Clinical Cancer Research ·Ursula A. Matulonis, Michael J. Birrer, David M. O’Malley, Kathleen N. Moore, Jason Konner, Lucy Gilbert, Lainie P. Martin, Todd M. Bauer, Amit M. Oza, Karim Malek, Jan Pinkas, Stella K. Kim	2018	56

About Lucy Gilbert

Lucy Gilbert is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Microbiology, Cancer Research and Oncology, having authored 160 papers that have together received 3.5k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (67 papers), Endometrial and Cervical Cancer Treatments (55 papers), Cancer Genomics and Diagnostics (25 papers), Genetic factors in colorectal cancer (20 papers), Cancer Immunotherapy and Biomarkers (15 papers), PARP inhibition in cancer therapy (12 papers), Endometriosis Research and Treatment (11 papers) and Cervical Cancer and HPV Research (11 papers). The work is most often cited by research in Reproductive Medicine (1.4k citations), Obstetrics and Gynecology (740 citations), Oncology (1.1k citations), Endocrinology, Diabetes and Metabolism (437 citations) and Pathology and Forensic Medicine (448 citations). Lucy Gilbert has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Ri‐Cheng Chian, Seang Lin Tan, Jack Y.J. Huang, William Buckett, David M. O’Malley, Ana Oaknin, Hananel Holzer, Kathleen N. Moore, G. Stanimir and Diane Provencher. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Annals of Oncology, International Journal of Gynecological Cancer and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact